Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung cancer: A systematic review.

There is debate regarding the use of stereotactic ablative radiotherapy (SABR) or surgery for patients with early stage non-small cell lung cancer (NSCLC). This meta-analysis compared the clinical efficacy of SABR and lobectomy in stage I NSCLC patients.